Integrated Drug Development and Clinical Services for Small and Emerging Pharma
The path through drug development is marked by detours, roadblocks and very few shortcuts. At times you may feel that you’re the only person keeping your molecule on its critical path. Unexpected delays can lead to missed milestones, rework and delayed timelines – all setbacks that no one wants to explain to their investors.
The Quick to Care™ suite delivers a streamlined drug development program, designed specifically for small and emerging companies. This program combines your drug substance and drug product development and clinical manufacturing into a single solution to accelerate your discovery to proof of concept.